13F-HR filed by RTW INVESTMENTS, LP
RTW INVESTMENTS, LP filed this 13F-HR for the quarter ended 2019-06-30, filed 2019-08-14, with 52 holding rows worth $1,872,337,000.
- Accession
- 0001493152-19-012319
- Filer
- CIK 1493215
- Filed
- 2019-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2019
A holdings report, 52 entries on the cover page, a total value of $1,872,337,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,872,338,000 with VALUE read as thousands by filing date, 13F file number 028-16670. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerRTW MASTER FUND, LTD.028-16671
- included managerRTW Innovation Master Fund Ltd.028-19525
- included managerRTW Special Purpose Fund I, LLC
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 16,587,491 | $248,812,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 2,198,094 | $159,494,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 3,137,361 | $141,181,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 6,152,103 | $96,896,000 | thousands by filing date | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 3,355,466 | $92,570,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 604,236 | $91,814,000 | thousands by filing date | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 3,521,856 | $90,967,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 6,320,350 | $75,149,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 1,561,918 | $70,833,000 | thousands by filing date | |
| AXONICS INC | 05465P101 | COM | 1,534,605 | $62,873,000 | thousands by filing date | |
| MASIMO CORP COM | 574795100 | Stock | 372,258 | $55,399,000 | thousands by filing date | |
| VERICEL CORP | 92346J108 | COM | 2,606,771 | $49,242,000 | thousands by filing date | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 1,883,180 | $41,411,000 | thousands by filing date | |
| TRANSPORTATION & LOGISTI | 438083107 | COM | 2,054,932 | $40,215,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 13,864,383 | $37,157,000 | thousands by filing date | |
| MYOKARDIA INC | 62857M105 | COM | 723,455 | $36,274,000 | thousands by filing date | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 3,722,950 | $33,879,000 | thousands by filing date | |
| TRANSLATE BIO INC. | 89374L104 | Common Stock | 2,439,250 | $30,808,000 | thousands by filing date | |
| AGENUS INC | 00847G705 | COM NEW | 10,084,214 | $30,253,000 | thousands by filing date | |
| ILLUMINA INC | 452327109 | COM | 82,000 | $30,188,000 | thousands by filing date | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 1,120,346 | $29,689,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 255,270 | $26,293,000 | thousands by filing date | |
| STANDARD BIOTOOLS INC | 34385P108 | COM | 2,077,471 | $25,594,000 | thousands by filing date | |
| APYX MEDICAL CORPORATION | 03837C106 | COM | 3,399,899 | $22,847,000 | thousands by filing date | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 844,289 | $21,740,000 | thousands by filing date | |
| REGENXBIO INC | 75901B107 | COM | 368,040 | $18,906,000 | thousands by filing date | |
| LA JOLLA PHARMACEUTICAL CO | 503459604 | COM PAR $.0001 2 | 2,011,340 | $18,605,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 807,870 | $17,765,000 | thousands by filing date | |
| TRANSMEDICS GROUP INC | 89377M109 | COM | 507,007 | $14,698,000 | thousands by filing date | |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 376,647 | $14,689,000 | thousands by filing date | |
| QUOTIENT LTD | G73268107 | SHS | 1,544,047 | $14,437,000 | thousands by filing date | |
| Johnson & Johnson | 478160104 | COM | 93,912 | $13,080,000 | thousands by filing date | |
| ODONATE THERAPEUTICS INC | 676079106 | COM | 339,156 | $12,444,000 | thousands by filing date | |
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 5,533,093 | $11,509,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 144,595 | $11,300,000 | thousands by filing date | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 988,319 | $11,089,000 | thousands by filing date | |
| SILK ROAD MEDICAL INC | 82710M100 | COMMON STOCK | 223,722 | $10,842,000 | thousands by filing date | |
| MYRIAD GENETICS INC | 62855J104 | COM | 376,586 | $10,462,000 | thousands by filing date | |
| PRINCIPIA BIOPHARMA INC | 74257L108 | COM | 270,948 | $8,993,000 | thousands by filing date | |
| BRAINSWAY LTD | 10501L106 | CMN | 597,216 | $6,263,000 | thousands by filing date | |
| CHARDAN HEALTHCARE ACQUISITI | 15957A207 | UNIT 12/13/2023 | 600,000 | $6,113,000 | thousands by filing date | |
| PERSONALIS INC | 71535D106 | COMMON STOCK | 225,000 | $6,109,000 | thousands by filing date | |
| CAREDX INC | 14167L103 | COM | 154,616 | $5,565,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 31,448 | $4,452,000 | thousands by filing date | |
| MOTUS GI HLDGS INC | 62014P108 | COM | 1,126,144 | $3,412,000 | thousands by filing date | |
| VIVUS INC | 928551AA8 | CONV BND | 4,000,000 | $3,128,000 | thousands by filing date | |
| NEURONETICS INC | 64131A105 | COM | 168,274 | $2,105,000 | thousands by filing date | |
| VIVEVE MED INC | 92852W204 | COM NEW | 4,480,565 | $1,703,000 | thousands by filing date | |
| Viewra, Inc | 92672L107 | COM | 159,247 | $1,403,000 | thousands by filing date | |
| SOLID BIOSCIENCES INC COM NEW | 83422E105 | Stock | 145,225 | $835,000 | thousands by filing date | |
| OPTINOSE INC | 68404V100 | COM | 87,615 | $620,000 | thousands by filing date | |
| CHEMOMAB THERAPEUTICS LTD SPONSORED ADS | 03280X102 | ADR | 51,918 | $233,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001493152-19-012319 | this filing | 2019-08-14 | acceptance time not in the bulk data set |